IRVINE, Calif., Oct. 31, 2023 /PRNewswire/ -- VESICA HEALTH, INC., a multi-omics, liquid biopsy company transforming the management of hematuria patients and improving the early detection of bladder ...

Dr. Kates’ experience as chair of the landmark Phase 3 BRIDGE bladder cancer trial and dedication to patient care will be invaluable to the ...

Rahuldev Bhalla, MD, a fellowship-trained board-certified urologist, joined the combined medical group of RWJBarnabas Health and Rutgers Health, the systems said March 10. Dr. Bhalla will provide ...

Urologic oncologist Dr. Isaac Powell sits down with TODAY’s Al Roker to discuss his research into why Black men are more likely to be diagnosed with and die from prostate cancer. He talks about ...

Prostate-specific membrane antigen antibody drug conjugate (PSMA ADC): A phase I trial in men with prostate cancer previously treated with taxane. Background: Our study investigates the influence of ...

Mary Bird Perkins Metairie clinic adds infusion, pharmacy, exam rooms, and research space to improve urologic cancer care.

Last year's American Urological Association (AUA) annual meeting featured a panel discussion regarding the history, current state, and future plans for the Women in Urologic Oncology, and a few months ...

CORAL GABLES, Fla., July 15, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for ...